These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24401719)

  • 1. Investigating the role of cardiovascular biomarkers in children with pre-dialysis chronic kidney disease: a substitute to echocardiography to detect increased left ventricular mass?
    Clothier JC; Simpson JM; Turner C; Dalton RN; Rasmussen P; Rawlins D; Booth CJ; Peacock JL; Sinha MD
    Nephron Clin Pract; 2013; 124(3-4):191-201. PubMed ID: 24401719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease.
    Sinha MD; Turner C; Booth CJ; Waller S; Rasmussen P; Goldsmith DJ; Simpson JM
    Pediatr Nephrol; 2015 Oct; 30(10):1843-52. PubMed ID: 25975437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular hypertrophy and endothelial dysfunction in chronic kidney disease.
    Poulikakos D; Ross L; Recio-Mayoral A; Cole D; Andoh J; Chitalia N; Sharma R; Carlos Kaski J; Banerjee D
    Eur Heart J Cardiovasc Imaging; 2014 Jan; 15(1):56-61. PubMed ID: 23811493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [B-type natriuretic peptide as a marker of cardiac dysfunction in children with chronic kidney disease].
    Drożdż T; Kwinta P; Kordon Z; Sztefko K; Rudziński A; Zachwieja K; Miklaszewska M; Czarnecka D; Drożdż D
    Pol Merkur Lekarski; 2018 Apr; 44(262):171-176. PubMed ID: 29775443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography.
    Matsumoto M; Io H; Furukawa M; Okumura K; Masuda A; Seto T; Takagi M; Sato M; Nagahama L; Omote K; Hisada A; Horikoshi S; Tomino Y
    J Nephrol; 2012; 25(5):794-801. PubMed ID: 22241636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cystatin C level is associated with left atrial enlargement, left ventricular hypertrophy and impaired left ventricular relaxation in patients with stage 2 or 3 chronic kidney disease.
    Sakuragi S; Ichikawa K; Yamada K; Tanimoto M; Miki T; Otsuka H; Yamamoto K; Kawamoto K; Katayama Y; Tanakaya M; Ito H
    Int J Cardiol; 2015; 190():287-92. PubMed ID: 25932809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in pre-dialysis patients with chronic kidney disease.
    Shi B; Ni Z; Zhou W; Yu Z; Gu L; Mou S; Fang W; Wang Q; Cao L; Yan Y; Qian J
    Eur J Intern Med; 2010 Oct; 21(5):444-8. PubMed ID: 20816602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure control and left ventricular mass in children with chronic kidney disease.
    Sinha MD; Tibby SM; Rasmussen P; Rawlins D; Turner C; Dalton RN; Reid CJ; Rigden SP; Booth CJ; Simpson JM
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):543-51. PubMed ID: 21115627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of left ventricular hypertrophy in chronic kidney disease: an echocardiographic evaluation.
    Sambi RS; Gaur AK; Hotchandani R; Aggarwal KK; Kaur S; Gupta M; Jain S; Krishna CK; Chopra HK; Anand V; Srivastava S; Gupta R; Parashar SK
    Indian Heart J; 2011; 63(3):259-68. PubMed ID: 22734347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible correlation among echocardiographic measures, serum brain natriuretic peptide, and angiotensin II levels in hypertensive kidney transplanted children.
    Gheissari A; Sabri M; Pirpiran M; Merrikhi A
    Exp Clin Transplant; 2013 Apr; 11(2):128-33. PubMed ID: 23477424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
    Mitsnefes MM; Betoko A; Schneider MF; Salusky IB; Wolf MS; Jüppner H; Warady BA; Furth SL; Portale AA
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):45-52. PubMed ID: 29025789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiposity, Sex, and Cardiovascular Disease Risk in Children With CKD: A Longitudinal Study of Youth Enrolled in the Chronic Kidney Disease in Children (CKiD) Study.
    Brady TM; Roem J; Cox C; Schneider MF; Wilson AC; Furth SL; Warady BA; Mitsnefes M
    Am J Kidney Dis; 2020 Aug; 76(2):166-173. PubMed ID: 32389356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.
    Nitta K; Iimuro S; Imai E; Matsuo S; Makino H; Akizawa T; Watanabe T; Ohashi Y; Hishida A
    Clin Exp Nephrol; 2019 Jan; 23(1):85-98. PubMed ID: 29951723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease--a prospective observational study.
    Peiskerová M; Kalousová M; Danzig V; Míková B; Hodková M; Němeček E; Bani-Hani A; Ambrož D; Benáková H; Linhart A; Zima T; Tesař V
    BMC Nephrol; 2013 Jul; 14():142. PubMed ID: 23844967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
    Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study.
    Mitsnefes MM; Kimball TR; Kartal J; Witt SA; Glascock BJ; Khoury PR; Daniels SR
    J Pediatr; 2006 Nov; 149(5):671-5. PubMed ID: 17095341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.
    Vickery S; Price CP; John RI; Abbas NA; Webb MC; Kempson ME; Lamb EJ
    Am J Kidney Dis; 2005 Oct; 46(4):610-20. PubMed ID: 16183415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
    Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
    Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hemoglobin concentration on plasma B-type natriuretic peptide level and left ventricle echocardiographics characteristics in chronic kidney disease patients.
    Rasić S; Hadzović-Dzuvo A; Tomić M; Uncanin S; Corić S
    Coll Antropol; 2009 Dec; 33 Suppl 2():141-4. PubMed ID: 20120531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.